Bo Cai, MD
Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Bo Cai, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:11 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07297173 · Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R LeukemiaBeijing 302 Hospital · recruiting · Relapsed Leukemia, Refractory Leukemia · principal investigator
- Ph2NCT07238686 · Venetoclax-containing Therapy Combined With Microtransplant for Intermediate-risk and Higher MDSBeijing 302 Hospital · recruiting · Myelodysplastic Syndromes · principal investigator
- Ph2NCT07078591 · Venetoclax-containing Therapy Combined With Microtransplant for Newly Diagnosed AMLBeijing 302 Hospital · recruiting · Acute Myeloid Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:11 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in acute myeloid leukemia.